Headline News about Gilead Sciences![]() ![]()
Peering Into Gilead Sciences's Recent Short Interest
September 06, 2024
Via Benzinga
![]()
Unveiling 10 Analyst Insights On Gilead Sciences
September 04, 2024
Via Benzinga
![]() ![]()
Gilead Sciences Options Trading: A Deep Dive into Market Sentiment
September 03, 2024
Via Benzinga
![]() ![]() Via Benzinga
![]() Via Benzinga
![]()
Peering Into Gilead Sciences's Recent Short Interest
August 20, 2024
Via Benzinga
![]() ![]() ![]() ![]()
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
August 15, 2024
Via Benzinga
Exposures
Product Safety
![]()
Expert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
August 15, 2024
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Gilead Sciences (GILD) Q2 2024 Earnings Call Transcript
August 08, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|